Government urged to boost domestic R&D field via tax breaks, etc.

As part of measures to gear up the domestic pharmaceutical companies' competitiveness in the global BT sector, the government should push up with a variety of R&D investment stimulus measures including more tax benefits and flexible price management of drugs, according to pharmaceutical sources.

The source cited Canadian government's introduction of better tax breaks granted to R&D spending ...